NEW YORK (GenomeWeb) – CRISPR-Cas9 genome editing has the potential to heal a variety of diseases, but the problem of off-target effects is a challenge researchers have yet to surmount.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.